Lyrebird Health came out of one of Australia's best voice-AI shops. The transcription quality is exceptional — particularly for accented speech, which is where most clinical scribes still struggle. If you're evaluating purely on voice quality, Lyrebird is the answer.
The 47-second difference
I measured this myself over 60 consults — 30 with Lyrebird, 30 with MedMETs. Both produced sign-off-ready notes. The time from end-of-consult to sign-off averaged 1m 22s on Lyrebird and 35s on MedMETs. The difference — 47 seconds per consult — is workflow, not transcription.
Lyrebird's note lives in a dedicated app. To get it into Best Practice, I copy and paste. MedMETs pushes the structured note directly into the EHR fields. The voice is comparable; the next step is what differs.
47 seconds doesn't sound like much
Per consult, no. Per 30-consult day, that's 23 minutes. Per month, that's 9 hours of clinician time. Per year, it's roughly 110 hours per full-time GP. At average chargeable rates, the workflow gap is worth $32,000 per clinician per year.
I'm not saying Lyrebird is bad. I'm saying the math compounds.
Where Lyrebird stays ahead
Voice quality on non-standard accents. I have several patients whose accents MedMETs occasionally struggles with — usually rapid Mandarin-inflected English. Lyrebird handles these noticeably better. If your patient population is heavily multilingual, Lyrebird's voice tech is a real consideration.
Where MedMETs is structurally different
MedMETs isn't a voice product. It's a clinical platform that happens to include a voice product. The scribe is one feature of a wider system — care plans, screening, patient app, sync, billing flags. If voice quality is your only criterion, that platform context might be irrelevant. If you're solving for the whole consult, it's central.
Voice + everything that comes after it — natively integrated.See the MedMETs platform